An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis.
Arvin A, Campadelli-Fiume G, Mocarski E, et al., editors.
Cambridge: Cambridge University Press; 2007.
Table of contents
Chapter 38, VZV: molecular basis of persistence (latency and reactivation).
Cohen JI.
Chapter 37, VZV: pathogenesis and the disease consequences of primary infection.
Moffat J, Ku CC, Zerboni L, et al.
Chapter 70, Varicella-zoster vaccine.
Gershon AA.
Chapter 34, Immunobiology and host response.
Koelle DM.
Chapter 68, Candidate anti-herpesviral drugs; mechanisms of action and resistance.
Biron KK.
Chapter 73, DNA vaccines for human herpesviruses.
Evans TG, Wloch M.
Chapter 7, Entry of alphaherpesviruses into the cell.
Campadelli-Fiume G, Menotti L.
Chapter 65, Antiviral therapy of varicella-zoster virus infections.
Gnann Jr. JW.
Chapter 48, HHV-6A, 6B, and 7: immunobiology and host response.
Wang FZ, Pellett PE.
Chapter 26, Reactivation and lytic replication of KSHV.
Lukac DM, Yuan Y.
Chapter 5, Genetic comparison of human alphaherpesvirus genomes.
Baines JD, Pellett PE.
Chapter 58, Simian varicella virus.
Mahalingam R, Gilden DH.
Chapter 40, VSV: persistence in the population.
Seward J, Jumaan A.
Chapter 67, New approaches to antiviral drug discovery (genomics/proteomics).
Prichard MN.
Chapter 50, Clinical and pathological aspects of EBV and KSHV infection.
Ambinder RF, Cesarman E.
Chapter 63, Subversion of innate and adaptive immunity: immune evasion from antibody and complement.
Hook LM, Friedman HM.
Chapter 22, Introduction to the human γ-herpesviruses.
Longnecker R, Neipel F.
Chapter 29, Effects on apoptosis, cell cycle and transformation, and comparative aspects of EBV with other known DNA tumor viruses.
Klein G, Ernberg I.
Chapter 53, The epidemiology of EBV and its association with malignant disease.
Hjalgrim H, Friborg J, Melbye M.
Chapter 46, HHV-6A, 6B, and 7: pathogenesis, host response, and clinical disease.
Mori Y, Yamanishi K.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on